Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AbbVie Inc.
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.
The timeline for a US resubmission of the closely watched PCSK9-targeting cholesterol treatment could be either Q2 or Q3 and approval will depend on whether the FDA needs to make a physical inspection of an Italian facility.
- Other Names / Subsidiaries
- Pharmacyclics, Inc.
- Stemcentrx, Inc.